|
STEMSOFT® is working on the next generation of our class-leading cell therapy manufacturing software. While this project is still under development, we are actively seeking people and institutions to join in our Subject Matter Expert and beta test process. This is a critical part of the STEMSOFT® software development life cycle and helps ensure that the products we build meet the needs of the cell therapy community. Early in the product development process, Subject Matter Experts or SMEs are asked to provide comments on designs and requirements. These comments are used to validate the specification for new releases of STEMSOFT® products. During the beta test period, real clients test the new version of STEMSOFT® products. The results of these tests are used to fine-tune the final release of the product.
If you are interested in participating in this process, please contact STEMSOFT® product management at suggestions@stemsoft.com.
This document contains forward–looking statements based on current expectations, forecasts and assumptions of STEMSOFT® that involve risks and uncertainties. Forward looking statements are subject to risks and uncertainties associated with STEMSOFT® business that could cause actual results to vary materially from those stated or implied by such forward-looking statements.
|